FIELD: medicine, oncology, clinical biochemistry.
SUBSTANCE: one should study biochemical values and level of tumor marker CA - 15.3 in mammary gland' secreta and at increased enzymatic activity in: aspartate aminotransferase (AST), alanine aminotransferase (ALT), amylase (Amyl), lactate dehydrogenase (LDH), increased level of albumin (ALB), total protein (Prot), uric acid (URAC), tumor marker CA - 15.3 and decreased activity of gamma-glutamyltranspeptidase (GGT) against comparison standard that characterizes the value of these parameters at galactorrhea syndrome of secretory character one should diagnose proliferative disease of mammary gland. The present innovation enables to detect mammary disease at its preclinical stages.
EFFECT: higher efficiency of screening diagnostics.
1 cl, 2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EXPRESS DIAGNOSTICS OF BREAST DISEASES | 2016 |
|
RU2620159C1 |
| METHOD FOR PREDICTING BENIGN MAMMARY PATHOLOGY | 2005 |
|
RU2283491C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR MALIGNANT AND BENIGN BREAST PATHOLOGY | 2013 |
|
RU2530557C1 |
| METHOD OF DIAGNOSING PATHOLOGY OF MAMMARY DUCTS OF MAMMARY GLAND | 2011 |
|
RU2487670C1 |
| METHOD FOR ASSAY OF OCCULT BLOOD IN BREAST SECRETION | 2002 |
|
RU2234091C1 |
| METHOD FOR LOCALISING NONPALPABLE RADIO- AND SONOGRAPHICALLY NEGATIVE INTRADUCTAL BREAST TUMOURS | 2013 |
|
RU2540365C2 |
| METHOD OF MAMMARY GLAND DIAGNOSTICS AT PRIMARY STAGE OF MANUAL MAMMARY GLAND EXAMINATION | 2020 |
|
RU2746062C1 |
| BREAST CYST FORMATIONS CLASSIFICATION | 2017 |
|
RU2639804C1 |
| METHOD OF TREATING CHRONIC DUCTOFORITIS | 2009 |
|
RU2418591C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF PANCREATIC CANCER AND CHRONIC PANCREATITIS | 2009 |
|
RU2421149C2 |
